Search Results - Jennifer G. Robinson

Refine Results
  1. 1
    Management of Familial Hypercholesterolemia: A Review of the Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia

    Management of Familial Hypercholesterolemia: A Review of the Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia by Jennifer G. Robinson

    Published 2013
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Curing Atherosclerosis Should Be the Next Major Cardiovascular Prevention Goal

    Curing Atherosclerosis Should Be the Next Major Cardiovascular Prevention Goal by Jennifer G. Robinson, Samuel S. Gidding

    Published 2014
    Get full text
    Carta
    Save to List
    Saved in:
  3. 3
    Safety of Aggressive Lipid Management

    Safety of Aggressive Lipid Management by Michael H. Davidson, Jennifer G. Robinson

    Published 2007
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    The 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk: a new paradigm supported by more evidence

    The 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk: a new paradigm supported by more evidence by Jennifer G. Robinson, Neil J. Stone

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk

    Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk by Jennifer G. Robinson, Songfeng Wang, Bruce A. Smith, Terry A. Jacobson

    Published 2009
    Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment

    Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment by A. St. Germain, Charles T. Peterson, Jennifer G. Robinson, D. Lee Alekel

    Published 2001
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Racial/Ethnic and Gender Gaps in the Use of and Adherence to Evidence-Based Preventive Therapies Among Elderly Medicare Part D Beneficiaries After Acute Myocardial Infarction

    Racial/Ethnic and Gender Gaps in the Use of and Adherence to Evidence-Based Preventive Therapies Among Elderly Medicare Part D Beneficiaries After Acute Myocardial Infarction by Julie C. Lauffenburger, Jennifer G. Robinson, Christine U. Oramasionwu, Gang Fang

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: Secondary analyses of longitudinal data from the Women's Health Initiative Memory Study (WHIMS)

    Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: Secondary analyses of longitudinal data from the Women's Health Initiative Memory Study (WHIMS) by Eric M. Ammann, James V. Pottala, Jennifer G. Robinson, Mark A. Espeland, William S. Harris

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Maternal Hyperlipidemia and the Risk of Preeclampsia: a Meta-Analysis

    Maternal Hyperlipidemia and the Risk of Preeclampsia: a Meta-Analysis by Cassandra N. Spracklen, Caitlin J. Smith, Audrey F. Saftlas, Jennifer G. Robinson, Kelli K. Ryckman

    Published 2014
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Safety and tolerability of dalcetrapib (RO4607381/JTT-705): results from a 48-week trial

    Safety and tolerability of dalcetrapib (RO4607381/JTT-705): results from a 48-week trial by Evan A. Stein, Eli M. Roth, James M. Rhyne, Tracy Burgess, David Kallend, Jennifer G. Robinson

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes

    Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes by James V. Pottala, Kristine Yaffe, Jennifer G. Robinson, Mark A. Espeland, Robert B. Wallace, William S. Harris

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Efficacy and Safety of Alirocumab as Add‐on Therapy in High–Cardiovascular‐Risk Patients With Hypercholesterolemia Not Adequately Controlled With Atorvastatin (20 or 40 mg) or Rosuvastatin (10 or 20 mg): Design and Rationale of the <scp>ODYSSEY OPTIONS</scp> Studies

    Efficacy and Safety of Alirocumab as Add‐on Therapy in High–Cardiovascular‐Risk Patients With Hypercholesterolemia Not Adequately Controlled With Atorvastatin (20 or 40 mg) or Rosu... by Jennifer G. Robinson, Helen M. Colhoun, Harold Bays, Peter H. Jones, Yunling Du, Corinne Hanotin, Stephen Donahue

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Association of fried food consumption with all cause, cardiovascular, and cancer mortality: prospective cohort study

    Association of fried food consumption with all cause, cardiovascular, and cancer mortality: prospective cohort study by Yangbo Sun, Buyun Liu, Linda Snetselaar, Jennifer G. Robinson, Robert B. Wallace, Lindsay L. Peterson, Wei Bao

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Association of Low‐Density Lipoprotein Cholesterol Levels with More than 20‐Year Risk of Cardiovascular and All‐Cause Mortality in the General Population

    Association of Low‐Density Lipoprotein Cholesterol Levels with More than 20‐Year Risk of Cardiovascular and All‐Cause Mortality in the General Population by Shuang Rong, Benchao Li, Liangkai Chen, Yangbo Sun, Yang Du, Buyun Liu, Jennifer G. Robinson, Wei Bao

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study

    Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODY... by Dean J. Kereiakes, Jennifer G. Robinson, Christopher P. Cannon, Christelle Lorenzato, Robert Pordy, Umesh Chaudhari, Helen M. Colhoun

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Genome-wide Association and Population Genetic Analysis of C-Reactive Protein in African American and Hispanic American Women

    Genome-wide Association and Population Genetic Analysis of C-Reactive Protein in African American and Hispanic American Women by Alex P. Reiner, Sandra Beleza, Nora Franceschini, Paul L. Auer, Jennifer G. Robinson, Charles Kooperberg, Ulrike Peters, Hua Tang

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction

    Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction by Maarit Jaana Korhonen, Jennifer G. Robinson, Izabela E. Annis, Ryan P. Hickson, J. Simon Bell, Juha Hartikainen, Gang Fang

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    First trimester prenatal screening biomarkers and gestational diabetes mellitus: A systematic review and meta-analysis

    First trimester prenatal screening biomarkers and gestational diabetes mellitus: A systematic review and meta-analysis by Brittney M. Donovan, Nichole Nidey, Elizabeth A. Jasper, Jennifer G. Robinson, Wei Bao, Audrey F. Saftlas, Kelli K. Ryckman

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  19. 19
    Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data

    Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data by Naveed Sattar, David Preiss, Jennifer G. Robinson, C. Stephen Djedjos, Mary Elliott, Ransi Somaratne, Scott M. Wasserman, Frederick J. Raal

    Published 2016
    Get full text
    Revisão
    Save to List
    Saved in:
  20. 20
    Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab

    Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab by Jennifer G. Robinson, Robert S. Rosenson, Michel Farnier, Umesh Chaudhari, William J. Sasiela, Laurence Merlet, Kathryn Miller, John J.P. Kastelein

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: